Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to enhance financial flexibility and ...

Manufacturers now face a rapidly evolving landscape where tariffs can shift overnight—from metals to paper to other key ...

Abbott's deal shakes up cancer diagnostics, new research confirms pandemic fatigue's impact on public compliance, and more in ...

AstraZeneca's $2 billion investment in Maryland will expand biologics manufacturing and establish a new clinical-stage ...

In today’s demanding clinical development environment—marked by complex protocols, tightened budgets, and heightened scrutiny from regulators, payers, and patients—fragmented trial planning puts ...